Press release
Pegfilgrastim Biosimilars Market 2022 - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast To 2030
According to The Business Research Company's Pegfilgrastim Biosimilars market report, the pegfilgrastim biosimilars market reached a value of nearly $902.1 million in 2020. The pegfilgrastim biosimilars market is expected to grow from $902.1 million in 2020 to $1,801.0 million in 2025 at a rate of 14.8%. The growth in the pegfilgrastim biosimilars market is mainly due to an increased prevalence of cancer and increasing adoption of the biosimilars. The pegfilgrastim biosimilars market is then expected to grow at a CAGR of 17.5% from 2025 and reach $4,037.1 million in 2030.
Increase in Cancer Incidence Rate : The rise in the number of cancer cases across the globe is likely to contribute to the growth of the pegfilgrastim biosimilars market during the forecast period. The incidence of cancer rises dramatically with age, most likely due to a build-up of risks for specific cancers that increase with age. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
View Our Buying Options For The Pegfilgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3428
The Pegfilgrastim Biosimilars market is segmented -
By Application : Chemotherapy Induced Neutropenia, Transplantation, Other
By Distribution Channel : Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Pegfilgrastim Biosimilars market.
Major competitors in the Pegfilgrastim Biosimilars market include Coherus BioSciences ,Sandoz (Novartis), Biocon/Mylan, Intas Biopharmaceuticals Ltd, Mundipharma GmbH
See The Full Pegfilgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/report/pegfilgrastim-biosimilars-market
The pegfilgrastim biosimilars market consists of the sales of pegfilgrastim biosimilars and related services by entities (organizations, sole traders and partnerships) that use them for the treatment of febrile neutropenia - a life-threatening complication of cancer chemotherapy and to increase the production of infection-fighting white blood cells following transplantation. It is a recombinant human granulocyte colony stimulating factor (G-CSF) and helps to stimulate the production of infection-fighting white blood cells (neutrophils) for the treatment of cancer patients undergoing chemotherapy. The drug has further applications where protection from infections where immune system is compromised, such as in bone marrow transplants.
The Table Of Content For The Pegfilgrastim Biosimilars Market Include:
1. Pegfilgrastim Biosimilars Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
……
20. Global Pegfilgrastim Biosimilars Market Competitive Landscape
21. Pegfilgrastim Biosimilars Market Pipeline Analysis
22. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market
23. Pegfilgrastim Biosimilars Market Future Outlook and Potential Analysis
24. Appendix
The Business Research Company's "Global Pegfilgrastim Biosimilars Opportunities And Strategies Market Report - Forecast To 2030" is the most comprehensive report available in market, providing data and statistics from over 60 geographies analyzed in more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. Additionally, it evaluates the market's historic and projected growth and identifies significant trends and strategies that can be used to outperform the competitors in the sector.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pegfilgrastim Biosimilars Market 2022 - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast To 2030 here
News-ID: 2792880 • Views: …
More Releases from The Business research company
Automated Machine Learning (AutoML) Market 2024-2033: Size, Share & Competitive …
The automated machine learning (automl) market size has grown exponentially in recent years. It will grow from $1.15 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 44.9%. The growth in the historic period can be attributed to complexity of machine learning, scarcity of data science talent, demand for speedy solutions, advancements in ai and computing power, cost efficiency.
The automated machine…
Menopausal Hot Flashes Market 2024-2033: Growth Trends, Forecast & Competitive L …
The menopausal hot flashes market size has grown strongly in recent years. It will grow from $14.06 billion in 2023 to $14.99 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to hormone replacement therapy, limited treatment options, awareness and education, shift in lifestyle management, alternative therapies:.
The menopausal hot flashes market size is expected to see…
Water Quality Testing Equipment Market 2024-2033: Trends, Analysis & Growth Fore …
The water quality testing equipment market size has grown strongly in recent years. It will grow from $4.32 billion in 2023 to $4.64 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to regulatory compliance, industrialization impact, public health concerns, environmental awareness.
The water quality testing equipment market size is expected to see strong growth in the…
Robotic Endoscopy Devices Market 2024-2033: Size, Share & Competitive Landscape …
The robotic endoscopy devices market size has grown rapidly in recent years. It will grow from $2.14 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to aging population, increasing demand for minimally invasive procedures, rising awareness of early disease detection, regulatory approvals, growing prevalence of gastrointestinal disorders.
The robotic endoscopy devices…
More Releases for Pegfilgrastim
Pegfilgrastim Biosimilars Market 2021 : Trends, Business Growth And Major Drivin …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports
‘Pegfilgrastim Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on.…
Pegfilgrastim Biosimilar Market to Exhibit 10% CAGR through 2026
Chemotherapy and/or radiotherapy is used for the treatment of most cancers. However, chemotherapy and radiotherapy have a very common side effect called neutropenia, and pegfilgrastim is required for its treatment. A study conducted on patients who received chemotherapy in 2016-2017 to evaluate the occurrence of chemotherapy-induced febrile neutropenia (CIFN) showed that, out of 200 patients, 9.5% patients developed neutropenia.
Click HERE to Get Synopsis of the Report- https://www.factmr.com/report/1494/pegfilgrastim-biosimilar-market
Neutropenia patients are highly…
Global Pegfilgrastim Market to 2026 - Industry Perspective, Comprehensive Analys …
The Pegfilgrastim Market report is intended to function as a supportive means to assess the Pegfilgrastim market ( https://bit.ly/37xB0L8 ) along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the clients in decision-making by presenting knowledgeable…
Global Pegfilgrastim Market Analysis Report 2019-2024
This report on Global Pegfilgrastim Market details about the market size, market growth rate and global forecast for the next five years i.e. 2024. The report is a complete analysis assessing the pricing trends, market consumption and sales forecasts. This study covers the competitive landscape by profiling the major market players. The vital information of the market is collected through authentic sources and reviewed by industry experts.
Pegfilgrastim is a PEGylated…
Pegfilgrastim Biosimilar Market: Industry Trends and Developments 2018-2028
Biosimilar is a medical product that is almost an identical copy of an existing drug manufactured by a different company. They require independent approval through clinical trials. The Biosimilar market is an expanding market. Approximately 30% of drugs sold globally are biopharma drugs. 40% of prescription drug spending in the US is on biologic drugs. Filgrastim is used as a medication for treating low levels of blood neutrophils caused by…
Pegfilgrastim Biosimilar Market Estimated to Record Highest CAGR by 2018 to 2028
Biosimilar is a medical product that is almost an identical copy of an existing drug manufactured by a different company. They require independent approval through clinical trials. The Biosimilar market is an expanding market. Approximately 30% of drugs sold globally are biopharma drugs. 40% of prescription drug spending in the US is on biologic drugs. Filgrastim is used as a medication for treating low levels of blood neutrophils caused by…
